Your browser doesn't support javascript.
loading
Widespread non-joint pain in early rheumatoid arthritis.
Schelin, Mec; Westerlind, H; Lindqvist, J; Englid, E; Israelsson, L; Skillgate, E; Klareskog, L; Alfredsson, L; Lampa, J.
Afiliação
  • Schelin M; Institute for Palliative Care, Region Skåne and Lund University, Lund, Sweden.
  • Westerlind H; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Lindqvist J; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Englid E; Division of Clinical Epidemiology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Israelsson L; Rheumatology Unit, Department of Medicine, Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden.
  • Skillgate E; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Klareskog L; Rheumatology Unit, Department of Medicine, Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden.
  • Alfredsson L; Rheumatology Unit, Department of Medicine, Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden.
  • Lampa J; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Scand J Rheumatol ; 50(4): 271-279, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33629632
ABSTRACT

Objective:

The aim of the study was to assess the development of widespread non-joint pain (WNP) in a cohort of patients with early rheumatoid arthritis (RA), the associated health-related quality of life (HRQoL), and clinical and demographic risk factors for WNP.

Method:

Incident cases with RA, from the Swedish population-based study Epidemiological Investigation of Rheumatoid Arthritis (EIRA), with a follow-up of at least 3 years, constituted the study population. WNP was defined as pain outside the joints in all four body quadrants and was assessed at the 3 year follow-up. Patients who reported WNP were compared to patients without WNP regarding HRQoL, measured by the Short Form-36, at 3 years, and clinical and demographic characteristics at the time of RA diagnosis.

Results:

A total of 749 patients constituted the study sample, of whom 25 were excluded after reporting already having severe pain before RA diagnosis. At the 3 year follow-up, 8% of the patients reported having WNP as well as statistically significant worse HRQoL. At the time of RA diagnosis, the patients with WNP had worse pain and pain-related features, while no difference was seen in the inflammatory parameters.

Conclusion:

WNP occurs in a substantial subset of patients with RA, also early in the course of the disease, and the HRQoL for these patients is significantly reduced. Patients who develop WNP at 3 years are already distinguishable at the time of diagnosis by displaying more pronounced pain ratings together with an average level of inflammatory disease activity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Dor Crônica Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Scand J Rheumatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Dor Crônica Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Scand J Rheumatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia
...